In Practice: RACGP Close the Gap Day event The theme, ‘Agency, Leadership, Reform’, highlights the role of leaders in improving Aboriginal and Torres Strait Islander health.
Deprescribing campaign focuses on environmental gains Advocacy backed by the RACGP highlights the benefits of deprescribing to both patients and the planet.
New guidance on driving and medicinal cannabis The GP-led, practical resources aim to support doctors considering medicinal cannabis treatment for patients who choose to drive.
In Practice: EOIs for Practice Owners Conference presentations Expressions of interest are now open to present at the RACGP’s annual conference for current and aspiring practice owners.
GPs to diagnose and prescribe for ADHD under ‘breakthrough’ plan West Australian GPs could soon be allowed to diagnose, initiate and manage treatment with stimulant medications.
‘A big difference’: Poisons Standard change brings hope Reduced paracetamol pack sizes are now in force, as a new report highlights the number of children hospitalised due to preventable medicine-related issues.
Dire 60-day script predictions fail to materialise As well as saving patients money, more pharmacies have opened than have closed since the policy first came into effect in September 2023.
‘Life-changing’ eczema drug to stay on PBS Dupixent was at high risk of coming off the PBS as soon as this month due to high demand, but negotiations have secured its continued listing.
President and Premier hit the parkrun trail The SA Premier and Health Minister joined the RACGP President and Adelaide GPs to showcase the benefits of parkrun and encourage social prescribing.
Federal Government backs ADHD prescribing consistency In response to last year’s Senate Inquiry, it also supports-in-principle calls to review relevant MBS items and pathways to GP assessments.